Business Wire

MN-ENTRUST

19.10.2020 13:02:08 CEST | Business Wire | Press release

Share
Entrust Launches Next-Generation, Secure Cloud-Based Direct-to-Card ID Desktop Issuance Solution

Entrust , a leading provider of trusted identities, payments and data protection, today announced the Sigma® Instant Desktop Issuance solution, an innovative direct-to-card solution for instant physical and mobile ID issuance. Designed for both cloud and on-premise deployment, the Sigma solution sets the standard for simple, secure and smart instant ID solutions across enterprise, healthcare, government, higher education and financial institutions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005238/en/

Today’s enterprises face a myriad of security challenges: From transitioning to digital operations during the pandemic, to managing the global rise in cyber-attacks, they must maintain a safe and secure flow of data − including the data stored on physical credentials. Within these organizations, Identity and Access Management professionals require a printing solution that is not only easy to integrate into their operations, but one that evolves to meet the growing needs of their company while assuring the highest level of data security. Sigma systems deliver a seamless user experience across the issuance process for desktop and mobile printing needs. It eliminates the frustrations of printer set-up with a modular design and an out-of-the-box implementation that takes less than 30 minutes for users to begin issuing identities.

Equipped with cloud-based APIs, Sigma systems bring issuance to the cloud without additional hardware — enabling instant printing for both physical IDs, badges and payment cards. Sigma systems are trusted IoT devices that help ensure organizations and their data are safe with an intelligent network and building connectivity for ultimate enterprise protection. With capabilities like tactile impressions, holographic and luster panel printing, Sigma printers make it highly difficult for counterfeiters to alter or recreate cards. Additionally, features like an inline magnetic stripe and smart card encoding secure your cards during the card printing process.

“With our Sigma platform, we’re proud to deliver a best-in-class desktop credential issuance solution that’s designed to work completely and securely within a cloud environment, allowing financial, enterprise, government, higher education and healthcare organizations to meet high-volume issuance demands without sacrificing security or ease of use. The Sigma system is ready to meet the issuance needs of today, and equally important, will evolve to meet tomorrow’s security and technology challenges with unlimited printing applications,” said Tony Ball, Senior Vice President and General Manager of Instant Issuance at Entrust. “Entrust has been a pioneer in direct-to-card identity issuance technology for decades, and our Sigma system takes it to a whole new level.”

Sigma systems offer the most advanced security architecture that keeps data protected at each step of the issuance process:

  • Encrypted connections: The connection and data sent between software and the printer are secure and encrypted. Sigma printers do not store customer data after successful printing is complete.
  • Secure boot: This feature prevents Sigma systems from booting up malware or other compromises are detected.
  • Trusted platform module (TPM): Organizations can store and manage user certificates and keys in the printer, allowing the printer to become a trusted internet of things (IoT) endpoint.

As large segments of the workforce continue operating remotely, Sigma systems are poised to meet the demands of a hybrid workforce with its physical and digital issuance platform. The Sigma system’s “Printer Dashboard” is available on mobile devices, allowing organizations to manage the printer from anywhere, without being tied to a desktop. Sigma systems also enable companies to pivot and move to a contactless ID Issuance experience, from online photo submission to validating the photo, printing the card, and ultimately delivering the card to the employee. Furthermore, the on-premises instant ID solution features a mobile enrollment functionality for added flexibility to issue IDs at various locations within a facility. Sigma systems use intelligent instant ID technology to streamline printing and eliminate manual workflows — bringing simplicity, security and flexibility to the issuance process.

“Whether your requirements demand an integrated, secure on-premises solution or a system that can grow with a distributed workforce via a secure cloud-hosted Identity Management offering, the Entrust Sigma solutions can meet your needs,” said Joe Franco, Director of Sales at Capture Technologies, an Entrust channel partner. “They are browser based and mobile ready and able to be deployed without the need for a heavy client to be installed. The certificate based integrated security features should put to rest any concerns about using the cloud for identity issuance or your printing solution being vulnerable to network attack.”

For more information about Sigma visit: https://www.entrust.com/c/meet-sigma .

About Entrust

Entrust keeps the world moving safely by enabling trusted identities, payments and data protection. Today more than ever, people demand seamless, secure experiences, whether they’re crossing borders, making a purchase, accessing e-government services or logging into corporate networks. Entrust offers an unmatched breadth of digital security and credential issuance solutions at the very heart of all these interactions. With more than 2,500 colleagues, a network of global partners, and customers in over 150 countries, it’s no wonder the world’s most entrusted organizations trust us. To learn more, visit www.entrust.com .

Link:

ClickThru

Social Media:

https://www.facebook.com/DiscoverEntrust

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye